Here you will find the share information for Qlife Holding AB. Our press releases and financial quarterly reports, our annual reports, calendar and information about our corporate governance work.

Dec 12, 2025 · Qlife Holding AB (“Qlife” or the “Company”) announced on 29 January 2025 that it had entered into an agreement for a credit facility of up to SEK 5.60 million (the “Credit Facility”) with JEQ …

Qlife Holding AB ("Qlife" or the "Company") announces an extension of the non-binding Letter of Intent regarding the potential reverse takeover (the "Transaction") with Hipro Biotechnology Co., Ltd. …

Feb 10, 2025 · Qlife Holding was formed in October 2019 and received the certification ISO 13485:2016 the same year, which means that Qlife meets all requirements for the manufacture and sale of in …

Dec 12, 2025 · "Partnering with Qlife enables Hipro to extend the reach of our innovative diagnostic solutions into key global markets. The integration of our platforms will deliver a seamless experience …

Här hittar du information om aktien för Qlife Holding AB. Våra pressmeddelanden, finansiella rapporter, årsredovisningar, kalender och information om vårt bolagsstyrningsarbete.

Mar 4, 2025 · To drive successful execution and accelerate growth, Qlife proposes to strengthen its Board with three new members who bring valuable expertise in life sciences and commercialization, …

Dec 12, 2025 · Qlife Holding AB ("Qlife" or the "Company") is proud to announce that its Egoo Health blood testing platform will play a central role in a groundbreaking project launched by Hipro …

Nov 12, 2025 · Qlife Holding AB (“Qlife” or “the Company”) and Hipro Biotechnology Co., Ltd. (“Hipro”) are working on the planned reverse takeover, as announced in press releases on 5 June 2025 and 5 …

På Qlife arbetar vi mot följande vision: att göra hemmet till fokus för hälsa genom ny teknik som möjliggör ett brett utbud av blodtester av laboratoriekvalitet – direkt från vardagsrummet.